Aemetis Inc. is a renewable fuels and biochemicals company that develops and operates technologies designed to replace petroleum-based products with low- and negative-carbon alternatives. The company focuses on producing renewable natural gas, ethanol, biodiesel, and related co-products used in transportation fuel, agricultural feed, and industrial applications. Its current operations span North America and India, with business segments centered on California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Aemetis also works on biogas capture, carbon reduction solutions, and the commercialization of advanced fuel and chemical processes. Headquartered in Cupertino, California, Aemetis serves markets tied to decarbonization, low-carbon fuel standards, and renewable energy supply chains.
Website20400 Stevens Creek Boulevard
Cupertino, CA, 95014
United States
Detailed price information for Aemetis Inc (AMTX-Q) from The Globe and Mail including charting and trades.
CUPERTINO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, praised the unanimous passage of California Senate Bill 795, which will allow the state’s fuel retailers to utilize existing vapor recovery equipment to dispense E15 based on manufacturer certifications. Using a 15% blend of ethanol would reduce the cost of blended gasoline to California consumers by $2.7 billion per year, according to a UC Berkeley study.
Detailed price information for Aemetis Inc (AMTX-Q) from The Globe and Mail including charting and trades.
Aemetis Q2 2026: revenue +20%, positive gross profit, but heavy reliance on 45Z tax credits and high debt. Click for more on AMTX stock.
Dallas, Texas--(Newsfile Corp. - August 10, 2026) - Aemetis Inc. (NASDAQ: AMTX): Stonegate Capital Partners Updates Coverage on Aemetis Inc. (NASDAQ: AMTX). Aemetis' 2Q26 results made the operating inflection visible, as quarterly 45Z recognition, higher RNG production, and improved ethanol economics drove positive operating income and adj. EBITDA despite India OMC tender timing. Revenue increased 20% y/y and 15% q/q to $62.7M, below $68.6M consensus, while our normalized EPS estimate...
Investors talking about AMTX also mention
What share of all stock conversation is about AMTX?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% -0.01 | 0% +0 | 0% +0 | 0% -0.01 |
Of the messages about AMTX that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 0% -84.85 | 55.71% -31.19 | 81.22% -8.01 | 81.58% -2.8 | ||
| Bearish | 100% +84.85 | 44.29% +31.19 | 18.78% +8.01 | 18.42% +2.8 |
Of the messages about AMTX that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 73.13% | 48.69% | ||
| Technical Analysis | — | 0% | 26.87% | 33.18% | ||
| Analysts | — | 0% | 0% | 3.99% | ||
| Macro | — | 0% | 0% | 10.37% | ||
| Earnings | — | 0% | 0% | 3.7% | ||
| Controversies | — | 0% | 0% | 0.07% |
Of the messages about AMTX, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 91.67% | 87.15% | 88.95% | 77.94% | ||
| Newcomers | 8.33% | 12.85% | 11.05% | 22.06% |